[Pediatric Radiation Oncology in France: State of the Art].
Fiche publication
Date publication
août 2022
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BERNIER-CHASTAGNER Valérie
Tous les auteurs :
Bernier V, Laprie A, Demoor-Goldschmidt C,
Lien Pubmed
Résumé
Pediatric radiotherapy differs greatly from its practice in adults mainly because of the age (median age 6 years), which poses the problem of irradiation of healthy tissues in a growing organism, causing sequelae, difficult compliance and management of parents. These particularities require a dedicated education and specific organization that was set progressively concerning indications, quality control, exhaustive collection of native dosimetry, long-term follow-up and clinical and translational research, as well as accreditations to practice pediatric radiotherapy, in close collaboration with the French Society of Child and Adolescent Cancer and Leukemia (SFCE), under the aegis of the French Group of Pediatric Radiotherapy (GFRP). This organization is a pioneer in the development of pediatric radiotherapy quality controls, which are becoming the European standard and in the collection of native dosimetry integrated with the follow-up of possible late-effects, constituting the most important international database.
Mots clés
France, GFRP, Organisation, Organization, Pediatric, Radiation oncology, Radiothérapie-Pédiatrie
Référence
Cancer Radiother. 2022 08 25;: